Cetero Research

FDA inspection history in Houston, Texas, 2010 to 2011

2
Form 483s
1
Warning letter

Every document, by year

  • Warning letter
  • Form 483

2010: two Form 483s; 2011: one warning letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2010–11Two Form 483s and one warning letter, at Houston, Texas.
  2. 2010The longest 483 on file: 6 observations over 2 pages at Houston, Texas.

Cited most

Across all Cetero Research observations on file

  • 21 CFR 320.29
    Analytical methods for an in vivo bioavailability or bioequivalence study
    1

The complete Cetero Research file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2011-07-26Warning letter Warning letter$99
2010-12-10483 Form 483$99
2010-05-07483 Form 483$99

FEI number 1000117586 · most recent document Jul 26, 2011

About Cetero Research

How many FDA Form 483s has Cetero Research received?

FDA Intel has 2 Form 483s on file for Cetero Research; the most recent is dated Dec 10, 2010.

When was Cetero Research last inspected by FDA?

The most recent FDA inspection document on file for Cetero Research is a Form 483 dated Dec 10, 2010, for the site in Houston, Texas.

What did FDA cite at Cetero Research?

The regulations cited most in the observations on file for Cetero Research are 21 CFR 320.29 (Analytical methods for an in vivo bioavailability or bioequivalence study), 1 time.

Has Cetero Research received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Cetero Research; the most recent is dated Jul 26, 2011.

Cetero Research FDA Inspection History & 483s · FDA Intel